KYMR
Price
$74.28
Change
+$0.15 (+0.20%)
Updated
Jun 8, 12:23 PM (EDT)
Capitalization
6.1B
53 days until earnings call
Intraday BUY SELL Signals
OCUL
Price
$8.37
Change
+$0.12 (+1.45%)
Updated
Jun 8, 12:27 PM (EDT)
Capitalization
1.81B
63 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KYMR vs OCUL

Header iconKYMR vs OCUL Comparison
Open Charts KYMR vs OCULBanner chart's image
KYMR vs OCUL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
KYMR vs. OCUL commentary
Jun 08, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Hold and OCUL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2026
Stock price -- (KYMR: $74.13 vs. OCUL: $8.25)
Brand notoriety: KYMR and OCUL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 123% vs. OCUL: 46%
Market capitalization -- KYMR: $6.1B vs. OCUL: $1.81B
KYMR [@Biotechnology] is valued at $6.1B. OCUL’s [@Biotechnology] market capitalization is $1.81B. The market cap for tickers in the [@Biotechnology] industry ranges from $113.41B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileOCUL’s FA Score has 1 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • OCUL’s FA Score: 1 green, 4 red.
According to our system of comparison, OCUL is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 4 TA indicator(s) are bullish while OCUL’s TA Score has 5 bullish TA indicator(s).

  • KYMR’s TA Score: 4 bullish, 5 bearish.
  • OCUL’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, OCUL is a better buy in the short-term than KYMR.

Price Growth

KYMR (@Biotechnology) experienced а -8.95% price change this week, while OCUL (@Biotechnology) price change was -8.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.84%. For the same industry, the average monthly price growth was -6.78%, and the average quarterly price growth was -4.36%.

Reported Earning Dates

KYMR is expected to report earnings on Jul 31, 2026.

OCUL is expected to report earnings on Aug 10, 2026.

Industries' Descriptions

@Biotechnology (-6.84% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($6.1B) has a higher market cap than OCUL($1.81B). KYMR YTD gains are higher at: -4.729 vs. OCUL (-32.043). OCUL has higher annual earnings (EBITDA): -274.24M vs. KYMR (-306.36M). OCUL (667M) and KYMR (651M) have equal amount of cash in the bank . OCUL (79.5M) and KYMR (80.5M) have identical debt. OCUL (52M) and KYMR (51.5M) have equivalent revenues.
KYMROCULKYMR / OCUL
Capitalization6.1B1.81B338%
EBITDA-306.36M-274.24M112%
Gain YTD-4.729-32.04315%
P/E RatioN/AN/A-
Revenue51.5M52M99%
Total Cash651M667M98%
Total Debt80.5M79.5M101%
FUNDAMENTALS RATINGS
OCUL: Fundamental Ratings
OCUL
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
78
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KYMROCUL
RSI
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
78%
Momentum
ODDS (%)
Bearish Trend 4 days ago
76%
Bullish Trend 4 days ago
77%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 5 days ago
79%
Declines
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 7 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
84%
Aroon
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signal:
Gain/Loss:
OCUL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TTT69.460.79
+1.15%
ProShares UltraPro Short 20+ Year Trs
WMSB24.95-0.08
-0.31%
Weitz Multisector Bond ETF
BNDI46.82-0.29
-0.62%
NEOS Enhanced Income Aggregate Bond ETF
IUS64.80-1.40
-2.12%
Invesco RAFI™ Strategic US ETF
IEMG78.63-5.38
-6.40%
iShares Core MSCI Emerging Markets ETF

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with GPCR. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then GPCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-0.64%
GPCR - KYMR
63%
Loosely correlated
-3.79%
NRIX - KYMR
58%
Loosely correlated
-4.19%
WVE - KYMR
53%
Loosely correlated
-5.91%
FULC - KYMR
46%
Loosely correlated
+9.50%
OCUL - KYMR
44%
Loosely correlated
-6.25%
More

OCUL and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCUL has been loosely correlated with AMLX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if OCUL jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCUL
1D Price
Change %
OCUL100%
-6.25%
AMLX - OCUL
47%
Loosely correlated
-6.92%
WVE - OCUL
43%
Loosely correlated
-5.91%
MLTX - OCUL
41%
Loosely correlated
-4.38%
NRIX - OCUL
41%
Loosely correlated
-4.19%
EYPT - OCUL
39%
Loosely correlated
-3.92%
More